BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15361842)

  • 21. Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia.
    Kumagai T; Tefferi A; Jones L; Koeffler HP
    Leuk Res; 2005 May; 29(5):511-5. PubMed ID: 15755503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia.
    Rosti V; Massa M; Vannucchi AM; Bergamaschi G; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Guglielmelli P; Bruno E; Xu M; Hoffman R; Barosi G; ;
    Blood Cells Mol Dis; 2007; 38(3):280-6. PubMed ID: 17350297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells.
    Peng X; Mehta RG; Tonetti DA; Christov K
    Oncogene; 2005 Feb; 24(7):1296-301. PubMed ID: 15558014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
    Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C
    Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 3p microsatellite allelotyping in neuroblastoma: a report on the technical hurdles.
    Hoebeeck J; De Wilde B; Michels E; Combaret V; Yigit N; De Smet E; Van Roy N; Stanbridge E; Ru N; Laureys G; De Paepe A; Speleman F; Vandesompele J
    Cancer Invest; 2009 Oct; 27(8):857-68. PubMed ID: 19544108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer.
    Choi CH; Lee KM; Choi JJ; Kim TJ; Kim WY; Lee JW; Lee SJ; Lee JH; Bae DS; Kim BG
    Cancer Lett; 2007 Sep; 255(1):26-33. PubMed ID: 17467893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
    Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
    Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer.
    Qiu H; Lotan R; Lippman SM; Xu XC
    Genes Chromosomes Cancer; 2000 Jun; 28(2):196-202. PubMed ID: 10825004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer.
    Suzuki H; Ouchida M; Yamamoto H; Yano M; Toyooka S; Aoe M; Shimizu N; Date H; Shimizu K
    Lung Cancer; 2008 Jan; 59(1):24-31. PubMed ID: 17854949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.
    Cengiz B; Gunduz M; Nagatsuka H; Beder L; Gunduz E; Tamamura R; Mahmut N; Fukushima K; Ali MA; Naomoto Y; Shimizu K; Nagai N
    Oral Oncol; 2007 Mar; 43(3):241-7. PubMed ID: 16857411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.
    Martin ES; Cesari R; Pentimalli F; Yoder K; Fishel R; Himelstein AL; Martin SE; Godwin AK; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11517-22. PubMed ID: 14504409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.